Metered-dose inhaler (MDI)
Showing 1 - 25 of >10,000
Mucociliary Clearance Trial in United States (HFO MDI, HFA MDI)
Not yet recruiting
- Mucociliary Clearance
- HFO MDI
- HFA MDI
-
San Diego, California
- +4 more
Feb 23, 2023
Asthma Trial (Mometasone Furoate/Formoterol Fumarate (MF/F) 100/5 mcg MDI, Mometasone Furoate/Formoterol Fumarate (MF/F) 200/5
Completed
- Asthma
- Mometasone Furoate/Formoterol Fumarate (MF/F) 100/5 mcg MDI
- Mometasone Furoate/Formoterol Fumarate (MF/F) 200/5 mcg MDI
- (no location specified)
Feb 7, 2022
Pharmacokinetics Trial in San Antonio (Beclomethasone dipropionate BAI, Beclomethasone dipropionate MDI)
Completed
- Pharmacokinetics
- Beclomethasone dipropionate BAI
- Beclomethasone dipropionate MDI
-
San Antonio, TexasTeva Investigational Site
Nov 5, 2021
Asthma, COPD Trial (SCH No. 418131 (Mometasone Furoate/Formoterol Furoate abbreviated MF/F ))
Completed
- Asthma
- COPD
- SCH No. 418131 (Mometasone Furoate/Formoterol Furoate abbreviated MF/F )
- (no location specified)
Feb 7, 2022
COPD Trial in Worldwide (Treatment A : Budesonide, Glycopyrronium, and Formoterol Fumarate, Treatment B: Budesonide and
Not yet recruiting
- Chronic Obstructive Pulmonary Disease
- Treatment A : Budesonide, Glycopyrronium, and Formoterol Fumarate
- +2 more
-
Torrance, California
- +25 more
Sep 28, 2023
Asthma Trial (MF/F Metered Dose Inhaler (MDI) 25/5 mcg, MF/F MDI 50/5 mcg, MF/F MDI 100/5 mcg)
Withdrawn
- Asthma
- MF/F Metered Dose Inhaler (MDI) 25/5 mcg
- +6 more
- (no location specified)
Feb 7, 2022
Asthma Trial in United States (Albuterol dry powder inhaler, Albuterol HFA MDI (hydrofluoroalkane metered dose inhaler))
Completed
- Asthma
- Albuterol dry powder inhaler
- Albuterol HFA MDI (hydrofluoroalkane metered dose inhaler)
-
Los Angeles, California
- +8 more
Jan 18, 2022
Exercise Induced Bronchospasm Trial in United States (Budesonide/albuterol sulfate metered-dose inhaler 160/180 µg, Placebo
Completed
- Exercise Induced Bronchospasm
- Budesonide/albuterol sulfate metered-dose inhaler 160/180 μg
- Placebo metered-dose inhaler
-
Denver, Colorado
- +5 more
Jan 4, 2022
Asthma Trial in Worldwide (BFF MDI 160/9.6 µg BID (320/19.2µg/day), BD MDI 160 µg BID (320 µg/day))
Recruiting
- Asthma
- BFF MDI 160/9.6 μg BID (320/19.2μg/day)
- BD MDI 160 μg BID (320 μg/day)
-
Huntington Beach, California
- +52 more
Mar 9, 2023
COPD Trial in Batman, Mersin (VIDEO-TRAINING-SESSION ABOUT MDI USE)
Completed
- Chronic Obstructive Pulmonary Disease
- VIDEO-TRAINING-SESSION ABOUT MDI USE
-
Batman, Turkey
- +1 more
Sep 7, 2021
Asthma Trial (Mometasone furoate/formoterol (MF/F) MDI, Fluticasone propionate/salmeterol (F/SC) DPI)
Completed
- Asthma
- Mometasone furoate/formoterol (MF/F) MDI
- Fluticasone propionate/salmeterol (F/SC) DPI
- (no location specified)
Feb 7, 2022
Asthma, Patient Education Trial in Gaziantep (Demonstration method for the use of the Metered Dose Inhaler, Video watching
Not yet recruiting
- Asthma
- Patient Education
- Demonstration method for the use of the Metered Dose Inhaler
- Video watching method for the use of the Metered Dose Inhaler
-
Gaziantep, TurkeyHasan Kalyoncu University
Dec 6, 2022
Asthma Trial in Worldwide (Beclomethasone dipropionate BAI, Placebo BAI, albuterol/salbutamol 90 mcg)
Completed
- Asthma
- Beclomethasone dipropionate BAI
- +4 more
-
Hoover, Alabama
- +101 more
Nov 5, 2021
Asthma Trial in Saskatoon (salbutamol aqueous solution, salbutamol pressurized metered dose inhaler, )
Not yet recruiting
- Asthma
- salbutamol aqueous solution
- +2 more
-
Saskatoon, Saskatchewan, CanadaAsthma Research Lab University of Saskatchewan Room 346 Ellis Ha
Jul 26, 2023
Asthma Trial in Worldwide (BFF MDI 320/9.6 µg, BFF MDI 160/9.6 µg, BD MDI 320 µg)
Recruiting
- Asthma
- BFF MDI 320/9.6 μg
- +3 more
-
Saraland, Alabama
- +121 more
Aug 22, 2022
COPD Trial in Shanghai (PT010 (BGF MDI) 320/14.4/9.6 µg, PT010 (BGF MDI) 160/14.4/9.6 µg, PT003 (GFF MDI) 14.4/9.6 µg)
Completed
- Chronic Obstructive Pulmonary Disease
- PT010 (BGF MDI) 320/14.4/9.6 µg
- +2 more
-
Shanghai, ChinaResearch Site
Dec 23, 2020
Real-world, 52-week Prospective Study to Capture Reasons for
Not yet recruiting
- Pulmonary Disease, Chronic Obstructive (COPD)
- Budesonide Glycopyrronium bromide Formoterol fumarate pressurized Metered Dose Inhaler
- (no location specified)
Jun 13, 2023
Asthma Trial (SCH 32088 mometasone furoate (MF) metered-dose inhaler, Placebo metered-dose inhaler BID)
Withdrawn
- Asthma
- SCH 32088 mometasone furoate (MF) metered-dose inhaler
- Placebo metered-dose inhaler BID
- (no location specified)
Feb 7, 2022
Asthma Trial in Denver (Albuterol HFA-BOI, Albuterol HFA-MDI)
Completed
- Asthma
- Albuterol HFA-BOI
- Albuterol HFA-MDI
-
Denver, ColoradoNational Jewish Medical and Research Ceter
Nov 17, 2021
Asthma, Asthma in Children Trial in Coleraine, Derry / Londonderry (aflo™ digital respiratory management platform, Standard
Recruiting
- Asthma
- Asthma in Children
- aflo™ digital respiratory management platform
- Standard care
-
Coleraine, N.Ireland, United Kingdom
- +1 more
Feb 14, 2023
Asthma Trial in Worldwide (Beclomethasone dipropionate, Placebo, Albuterol/salbutamol)
Completed
- Asthma
- Beclomethasone dipropionate
- +2 more
-
Costa Mesa, California
- +130 more
Nov 5, 2021
Asthma Trial (BDA MDI, AS MDI)
Not yet recruiting
- Asthma
- BDA MDI
- AS MDI
- (no location specified)
Aug 15, 2022
Asthma Trial in Spartanburg (Fluticasone propionate pressurized metered dose inhaler, Flovent HFA pressurized metered dose
Completed
- Asthma
- Fluticasone propionate pressurized metered dose inhaler
- +2 more
-
Spartanburg, South CarolinaSite 1
Aug 31, 2021